Targeting the dna damage response for anti-cancer therapy
Éditeur :
Springer Nature Switzerland AG
ISBN :
9783030093365
Date de publication :
21 déc. 2018
Dimensions :
23,5 x 15,5 cm
Langue :
Anglais
Pays d'origine :
Suisse
As a result of all these observations there has been a great interest in targeting the DDR to provide anti-cancer agents thatmay have benefit as monotherapy in cancers with high background DNA damage levels or as a means to increase the efficacy of DNA damaging drugs and IR.